UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES AND EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): July 27, 2006
DYNAVAX TECHNOLOGIES CORPORATION
(Exact name of registrant as specified in charter)
| |
|
|
|
|
| Delaware |
|
000-50577 |
|
33-0728374 |
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer
Identification No.) |
| |
|
|
| 2929 Seventh Street, Suite 100 |
| Berkeley, California 94710 |
| (Address of principal executive offices and zip code) |
Registrant’s telephone number, including area code: (510) 848-5100
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02. Results of Operations and Financial Condition.
On July 27, 2006, Dynavax Technologies Corporation issued a press release announcing its
fiscal 2006 second quarter financial results. A copy of the press release is attached as Exhibit
99.1 to this current report and is incorporated herein by reference.
The information in this current report and in the accompanying exhibit shall not be deemed to
be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or
otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities
Act of 1933, as amended. The information contained in this current report and in the accompanying
exhibit shall not be incorporated by reference into any filing with the U.S. Securities and
Exchange Commission made by Dynavax Technologies Corporation, whether made before or after the date
hereof, regardless of any general incorporation language in such filing.
Item 9.01 Financial Statements and Exhibits.
| |
|
|
| Exhibit |
| Number |
|
Description |
| |
| 99.1 |
|
Press Release, dated July 27,
2006, announcing Dynavax Technologies
Corporation Fiscal 2006 Second Quarter Financial Results. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
| |
|
|
|
|
| |
Dynavax Technologies Corporation
|
|
| Dated: July 27, 2006 |
By: |
/s/ Deborah A. Smeltzer
|
|
| |
|
Deborah A. Smeltzer, Vice President |
|
| |
|
Operations and Chief Financial Officer |
|